AMVAZ Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Amvaz, and when can generic versions of Amvaz launch?
Amvaz is a drug marketed by Dr Reddys Labs Inc and is included in one NDA.
The generic ingredient in AMVAZ is amlodipine maleate. There are fifty drug master file entries for this compound. Additional details are available on the amlodipine maleate profile page.
Summary for AMVAZ
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 65 |
Patent Applications: | 511 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AMVAZ at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for AMVAZ
US Patents and Regulatory Information for AMVAZ
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dr Reddys Labs Inc | AMVAZ | amlodipine maleate | TABLET;ORAL | 021435-001 | Oct 31, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Dr Reddys Labs Inc | AMVAZ | amlodipine maleate | TABLET;ORAL | 021435-002 | Oct 31, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Dr Reddys Labs Inc | AMVAZ | amlodipine maleate | TABLET;ORAL | 021435-003 | Oct 31, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |